Max Healthcare Institute Limited’s Nomination and Remuneration Committee has approved the grant of 3,61,827 stock options to eligible employees under its Employee Stock Option Scheme 2022. This decision was made during a meeting held on August 13, 2026. The details of the grant, including exercise price and vesting schedule, are outlined in an annexure to the disclosure. This move is intended to incentivize and retain key talent within the organization.
Stock Option Grant Approved
The Nomination and Remuneration Committee (NRC) of Max Healthcare Institute Limited convened on August 13, 2026, to approve the grant of stock options to its employees. During this meeting, the committee sanctioned the issuance of 3,61,827 stock options under the Max Healthcare Institute Limited – Employee Stock Option Scheme 2022. This initiative aims to align employee interests with the company’s long-term growth and value creation.
Scheme Details and Vesting
The stock options granted are convertible into fully paid-up equity shares, each with a face value of ₹10. The exercise price for these options is set at ₹800 per stock option. Vesting of these options is subject to the fulfillment of pre-vesting conditions and will occur no earlier than one year and no later than five years from the date of grant, as determined by the Nomination and Remuneration Committee.
Furthermore, the options can be exercised within three years from the respective date of vesting. The terms and conditions governing these stock options are in line with the company’s established Employee Stock Option Scheme 2022, administered by the Nomination and Remuneration Committee. The meeting of the NRC took place from 7:50 AM to 8:20 AM IST.
Source: BSE
